Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing

Electroporation for DNA immunization: clinical application

(2010) Sylvia van Drunen Littel-van den Hurk et al.   Expert Review of Vaccines

The cellular mechanism by which complementary Id+ and anti-Id antibodies communicate: T cells integrated into idiotypic regulation

(2010) Johanne T Jacobsen et al.   IMMUNOLOGY AND CELL BIOLOGY

Importance of Achieving a Complete Response in Multiple Myeloma, and the Impact of Novel Agents

(2010) Asher A. Chanan-Khan et al.   JOURNAL OF CLINICAL ONCOLOGY

Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines

(2010) Pier Adelchi Ruffini et al.   VACCINE

The role of complete response in multiple myeloma

(2009) J.-L. Harousseau et al.   BLOOD

Review: To What Extent are T Cells Tolerant to Immunoglobulin Variable Regions?

(2009) B. Bogen et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Multiple myeloma

(2008) R. A. Kyle et al.   BLOOD

Roles of Idiotype-Specific T Cells in Myeloma Cell Growth and Survival: Th1 and CTL Cells Are Tumoricidal while Th2 Cells Promote Tumor Growth

(2008) S. Hong et al.   CANCER RESEARCH

Growth inhibition of myeloma cells by anti-idiotype antibodies in the absence of membrane-bound immunoglobulin

(2008) Shiri Moshitzky et al.   IMMUNOLOGY AND CELL BIOLOGY

Individualizing Treatment of Patients With Myeloma in the Era of Novel Agents

(2008) Jesús San-Miguel et al.   JOURNAL OF CLINICAL ONCOLOGY

Multiple Myeloma Cancer Stem Cells

(2008) Carol Ann Huff et al.   JOURNAL OF CLINICAL ONCOLOGY